On Thursday, May 23, Senators Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the chair and ranking Democrat of the Health, Education, Labor and Pensions (“HELP”) Committee released bipartisan discussion draft…
The 340B annual recertification period for STD, TB and Title X grantees started on May 13, 2019 and ends on June 10, 2019. Recertification must be completed through the 340B…
On Thursday May 9, 2019 the House Energy and Commerce Committee, Health Subcommittee held a hearing on Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain. In the latter half…
Earlier today, HHS issued a Final Rule that will require pharmaceutical manufacturers to disclose the wholesale acquisition cost (“WAC”) in direct-to-consumer TV advertisements for all Medicare and Medicaid covered drugs. …
On May 6, 2019, the U.S. District Court for the District of Columbia ruled that CMS acted outside its statutory authority in adopting an almost 30% reimbursement cut for Medicare…
The Office of Pharmacy Affairs (OPA) recently published an update regarding the 340B ceiling price website. The update announces that HRSA will publish additional pricing data elements in the OPAIS…